A Cost–Utility Analysis of Mechanical Thrombectomy as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Large-Vessel Ischemic Stroke | Zendy

Anthony Kim | Zendy; Mai N. NguyenHuynh | Zendy; S. Claiborne Johnston | Zendy

Open Access

A Cost–Utility Analysis of Mechanical Thrombectomy as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Large-Vessel Ischemic Stroke

Author(s) -

Anthony Kim,

Mai N. NguyenHuynh,

S. Claiborne Johnston

Publication year - 2011

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.110.606889

Subject(s) - medicine , adjunct , stroke (engine) , tissue plasminogen activator , thrombolysis , plasminogen activator , ischemic stroke , fibrinolytic agent , acute stroke , vascular disease , cardiology , surgery , ischemia , myocardial infarction , mechanical engineering , engineering , philosophy , linguistics

Mechanical thrombectomy has the potential to improve recanalization rates and outcomes for patients with ischemic stroke, but potential gains could be offset by procedural complications and costs. We evaluated the cost and utility of combined intravenous (IV) tissue-type plasminogen activator (tPA) and mechanical thrombectomy compared to IV tPA alone for acute large-vessel ischemic stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research